MORGAN STANLEY PLC/CALL/PFIZER INC/60/0.1/21.03.25 Stock

Warrant

DE000MB550G5

Market Closed - Börse Stuttgart 04:41:53 2024-05-28 EDT
0.011 EUR +10.00% Intraday chart for MORGAN STANLEY PLC/CALL/PFIZER INC/60/0.1/21.03.25
1 month-21.43%
3 months-35.29%
Date Price Change
24-05-28 0.011 +10.00%
24-05-27 0.01 0.00%
24-05-24 0.01 -16.67%
24-05-23 0.012 +20.00%
24-05-22 0.01 -9.09%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 04:41 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB550G
ISINDE000MB550G5
Date issued 2023-03-31
Strike 60 $
Maturity 2025-03-21 (297 Days)
Parity 10 : 1
Emission price 0.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.116
Lowest since issue 0.008
Spread 0.029
Spread %72.50%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.3 USD
Average target price
31.92 USD
Spread / Average Target
+12.78%
Consensus